Table 3.

Previously identified potential salivary miRNA biomarkers associated with persistent post–concussive symptoms (PPCS).

	Association in other studies	Associated with PPCS in our cohort?	P–value in current study
Previously identified salivary miRNA that are expressed in current study
hsa–miR−203a−5p	PPCS (19)	Yes	0.00319
hsa–miR−148–3p	PPCS (19)	No	hsa–miR−148a−3p: 0.28106 hsa–miR−148b−3p: 0.52139
hsa–miR−1246	PPCS (19)	No	0.85564
Previously identified salivary miRNA that are not expressed or not measured in current study
hsa–miR−320c−1	PPCS (18)	No	NA
hsa–miR−133a−5p	PPCS (18)	No	NA
hsa–miR−769–5p	PPCS (18)	No	NA
hsa–let−7a−3p	PPCS (18)	Not measured	NA
hsa–miR−100–5p	PPCS (19)	No	NA
hsa–miR−148a−5p	PPCS (19)	Not measured	NA
hsa–miR−423–5p	PPCS (19)	No	NA
hsa–miR−92b−3p	PPCS (19)	No	NA
hsa–miR−1307–3p	PPCS (18)	No	NA
Salivary miRNA significantly expressed in current study that were not previously identified
hsa–miR−548y	NA	Yes	0.00015
hsa–miR−585–3p	NA	Yes	0.00015
hsa–miR−378h	NA	Yes	0.00015
hsa–miR−1323	NA	Yes	0.00015
hsa–miR−183–5p	NA	Yes	0.00015
hsa–miR−199a−3p+hsa–miR−199b−3p	NA	Yes	0.00015
hsa–miR−301a−5p	NA	Yes	0.00148
hsa–miR−626	NA	Yes	0.00244
hsa–miR−888–5p	NA	Yes	0.00518
hsa–miR−548e−5p	NA	Yes	0.00696
hsa–miR−200a−3p	NA	Yes	0.00789
hsa–miR−95–3p	NA	Yes	0.01010